|
 
- 积分
- 349
- 威望
- 349
- 包包
- 922
|
1 V4 q6 y4 Q( N, \6 g: r& [5 Z" r/ pCertainly we wish China goes to flourish and prosperous in the world in a good governance and order. This is the article published in 2006. It is still interesting as it is with current significance. I believe that our Chinese friends understand very well the tone of the author. If you read the whole thing you can find how ironic it is! A sarcasm, a highly ironnical remark, a harsh criticism to the SCR fanaticalists has been regarded as a praise by themselves and widely quoted for their promotion. It is internationally "face-lost"!2 {8 b7 I8 |' w0 \: t2 d
9 W+ Z5 e) u7 SGlobal Economics
. q0 y$ V* v" EBlinding Science: China's Race to Innovate& v$ v9 E; W( ~8 i! {8 ?. P7 q9 t
By Bruce Einhorn 3 p: _" }& D( M5 ?, P
on March 30, 2006- L+ T" U- [0 P, @: k* p
) U4 v( [" F4 M! c
Looking for the cutting edge of stem cell science? Instead of Stanford or Cambridge or Singapore, consider Shenzhen. That's where Chinese entrepreneur Sean Hu has set up one of the most radical businesses in the field. Hu is chairman of Beike Biotech, a joint venture involving the Shenzhen government, Peking University, and the Hong Kong University of Science and Technology.
3 U! \* a9 _* F. M4 x0 v
) `) R, R* Y8 V d7 D, f4 LLaunched last year, Beike specializes in stem cell treatments that doctors in the U.S. wouldn't dare to try experimentally, let alone commercially: taking stem cells from aborted fetuses and implanting them into patients with otherwise incurable diseases.- ~* u2 ^4 Z% ~% P$ E
4 A; h8 ]+ y. N A1 f9 e3 H, mIn the U.S., simply using stem cells from embryos is controversial. That's not the case in China, where regulators are also far more permissive about experimental therapies than their U.S. counterparts. So far, Hu and his doctors have treated more than 100 patients suffering from autism, ALS (Lou Gehrig's disease), crippling strokes, and other severe problems. Now, Hu plans to make Beike a nationwide company with global reach. "We will be able to apply the most advanced stem cell technology and use our network to collaborate with foreign biotech companies," he says.1 @% {2 P+ o7 i6 V! @3 ?, i
$ [: ^1 Y5 e4 W+ P
IT'S A SCIENCE. Hu's ambitions -- and the regulations that allow him to operate -- indicate just how far China is going in its attempt to build a more modern, flexible economy. In Beijing, innovation is the buzzword.
; D2 k3 u) e; d0 X) w J; H...
; W/ ~* U+ m* Ihttp://www.businessweek.com/stor ... as-race-to-innovate |
|
发表于 2012-9-8 17:06
